Navigation Links
For Medical Device Makers, Full Spectrum Software Presents a Live, One Hour Audio Course on Implementing QA Automation in an FDA Controlled Environment

For medical device makers, Full Spectrum Software presents a live, one hour audio course on Implementing QA Automation in an FDA Controlled Environment. The event is hosted by Foreign Exchange Translations. detailed information on the course can be found here

Southborough, MA and Halifax, NS (Vocus) July 22, 2009 -- Sponsored by Foreign Exchange Translations, Full Spectrum Software will present a live, one hour audio course on August 11th at 11:30 EDT. With major changes expected at the FDA, including increased scrutiny of complex medical devices, automating the QA process for medical device companies is more important than ever. This live, one hour audio presentation provides medical device software engineering and medical device QA professionals with practical guidelines on how to successfully implement QA automation in an FDA controlled software environment. The speaker discusses how to select and implement the correct tools, how to validate those tools and how to work with technical teams to develop the cost justification for automating the QA process.

This live one hour event is sponsored by Foreign Exchange Translations, leaders in medical translations and producers of dozens of live audio events of interest to the biotechnology and medical device industry. Full Spectrum Software, a national medical device software engineering and QA consulting firms and a recognized authority on both medical device software QA automation as well as medical device software engineering was selected by Foreign Exchange Translations to develop and present this live, one hour audio event. more information and a full course description can be found here

The live, one hour audio course will also feature a discussion of the FDA’s use of Static Analysis tools and the controversy surrounding some of the public statements made by the FDA. More importantly, the course will cover what the implications of these statements by the FDA mean to medical device companies and how this could impact the software QA processes.

About Foreign Exchange Translations
Foreign Exchange Translations, a leader in medical translations, has come to know how products are created, from R&D to clinical trials to marketing and all the steps in between. Their knowledge of the product life cycle means that they can speak the same language as their clients and build language translation into the process. Foreign Exchange Translations also hosts dozens of audio conferences every year that are of interest to the biotechnology and medical device community. You can find more information on their website more information on Foreign Exchange Translations here


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Varian Medical Systems Receives 510(k) Clearance for Fast and Accurate Acuros(TM) Radiotherapy Treatment Planning Capability
2. Symmetry Medical to Report Second Quarter 2009 Financial Results on August 6, 2009
3. Lumenis, Worlds Largest Medical Laser Company, Honored by Premier Healthcare Alliance for Exceeding Performance Expectations
4. Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009
5. Greenway Medical Technologies Executive, Justin Barnes, Re-Elected As Chairman of HIMSS Electronic Health Record Association
6. Orlando Regional Medical Center (ORMC) Implements PNA FISH(R) Tests to Help Provide Better Care for Patients with Bloodstream Infections
7. Novasys Medical Receives $18.95 Million in Second Tranche of Series D Financing
8. Owensboro Medical Health System Announces Results of Its Modified Dutch Auction Tender Offer
9. HealthCare Partners of Nevada and Fremont Medical Center Join Forces
10. All Allied Health Schools Helps Medical Coding Students Prepare for New Health Care World
11. Growth in African Medical Imaging Markets: Frost & Sullivan Examines the Potential
Post Your Comments:
(Date:11/25/2015)... Neb. (PRWEB) , ... November 25, 2015 , ... ... staffing companies, has been recognized once again for its stellar workplace culture with ... to Work.” , Medical Solutions’ Cincinnati office was named a finalist ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior government and UN ... African Centres of Excellence, and public R&D institutions, civil societies and other partners ... the 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... According to ... surgical robot is being more and more widely heralded as a breakthrough for performing ... Vinci method has over traditional laparoscopic surgery is that it can greatly reduce the ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, officials of ... Narconon network, announced the release of a new cutting edge recovery program that has ... been working with drug- and alcohol-addicted individuals with the purpose to free addicts from ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy Products, ... personal heating products business. Cozy Products explains what this means for business moving forward. ... with the Cozy Products business model: to sell personal heaters that reduce energy consumption, ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
(Date:11/25/2015)... 25, 2015  ARKRAY USA , ... provide evidence demonstrating the accuracy of its blood glucose ... Insulin Resistance, Diabetes and Cardiovascular Disease in ... Company,s GLUCOCARD ® 01 meter and the Assure ... The ability to accurately measure glucose levels in blood ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan plc (NYSE: ... with the New York State Attorney ... the Sherman Act, and other statutes with the Attorney General ... 2014, to cease marketing and selling the now generic version ... Allergan admits no liability, has released its counterclaims against ...
Breaking Medicine Technology: